Correlation Between Agape ATP and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agape ATP and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agape ATP and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agape ATP and MaxCyte, you can compare the effects of market volatilities on Agape ATP and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agape ATP with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agape ATP and MaxCyte.

Diversification Opportunities for Agape ATP and MaxCyte

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Agape and MaxCyte is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Agape ATP and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Agape ATP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agape ATP are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Agape ATP i.e., Agape ATP and MaxCyte go up and down completely randomly.

Pair Corralation between Agape ATP and MaxCyte

Given the investment horizon of 90 days Agape ATP is expected to under-perform the MaxCyte. But the stock apears to be less risky and, when comparing its historical volatility, Agape ATP is 1.02 times less risky than MaxCyte. The stock trades about -0.07 of its potential returns per unit of risk. The MaxCyte is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  357.00  in MaxCyte on August 30, 2024 and sell it today you would lose (5.00) from holding MaxCyte or give up 1.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Agape ATP  vs.  MaxCyte

 Performance 
       Timeline  
Agape ATP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agape ATP has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Agape ATP and MaxCyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agape ATP and MaxCyte

The main advantage of trading using opposite Agape ATP and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agape ATP position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind Agape ATP and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance